Accessibility Menu
 

Theracryf Plc

(LSE) TCF

Current Price$0.00
Market Cap$472.77M
Since IPO (2015)-99%
5 Year-97%
1 Year-2%
1 Month+13%

Theracryf Plc Financials at a Glance

Market Cap

$472.77M

Revenue (TTM)

$0.00

Net Income (TTM)

$4.93M

EPS (TTM)

$-0.13

P/E Ratio

-1.69

Dividend

$0.00

Beta (Volatility)

-0.14 (Low)

Price

$0.00

Volume

5,495,985

Open

$0.22

Previous Close

$0.21

Daily Range

$0.21 - $0.22

52-Week Range

$0.18 - $0.30

TCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Theracryf Plc

Industry

Biotechnology

Employees

9

CEO

Huw Jones, PhD

Headquarters

Nether Alderley, SK10 4TG, GB

TCF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-54%

Return on Capital

-47%

Return on Assets

-30%

Earnings Yield

-59.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$472.77M

Shares Outstanding

2.15B

Volume

5.50M

Avg. Volume

5.72M

Financials (TTM)

Gross Profit

$2.11M

Operating Income

$2.12M

EBITDA

$2.06M

Operating Cash Flow

$2.37M

Capital Expenditure

$0.00

Free Cash Flow

$2.37M

Cash & ST Invst.

$4.11M

Total Debt

$0.00

Theracryf Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$4.00K

-101.0%

Gross Margin

0.00%

N/A

Market Cap

$472.77M

N/A

Market Cap/Employee

$52.53M

N/A

Employees

9

N/A

Net Income

$1.31M

+10.0%

EBITDA

$1.31M

+9.9%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$3.50M

-6.2%

Accounts Receivable

$666.00K

+14.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-30.36%

N/A

Return on Invested Capital

-46.75%

N/A

Free Cash Flow

$699.00K

+45.0%

Operating Cash Flow

$699.00K

+45.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TRX.LTissue Regenix Group plc
$7.25+0.00%
CRTX.LCRISM Therapeutics Corporation
$12.75+0.00%
PRM.LProteome Sciences plc
$1.68+12.00%
OBD.LOxford BioDynamics Plc
$0.20+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About TCF

What is the current price of Theracryf Plc?

Theracryf Plc is trading at GBX 0.21 per share.

What is the 52-week range for Theracryf Plc?

Over the past 52 weeks, Theracryf Plc has traded between GBX 0.18 and GBX 0.30.

How much debt does Theracryf Plc have?

As of the most recent reporting period, Theracryf Plc reported total debt of N/A.

How much cash does Theracryf Plc have on hand?

Theracryf Plc reported $2.11M in cash and cash equivalents in its most recent financial results.

What is Theracryf Plc’s dividend yield?

Theracryf Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.